Skip to main content
رجوع
WAT logo

Waters Corporation

جودة البيانات: 100%
WAT
NYSE Healthcare Medical - Diagnostics & Research
KWD 301.81
▲ KWD 2.82 (0.94%)
القيمة السوقية: 17.96B
نطاق اليوم
KWD 299.43 KWD 307.00
نطاق 52 أسبوعًا
KWD 275.05 KWD 414.15
حجم التداول
657,227
متوسط 50 يوم / 200 يوم
KWD 344.13 / KWD 339.49
الإغلاق السابق
KWD 298.99

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (626 نظير)

المقياس السهم وسيط القطاع
P/E 28.0 0.4
P/B 7.0 2.9
ROE % 29.3 3.8
Net Margin % 20.3 3.9
Rev Growth 5Y % 3.2 10.0
D/E 0.6 0.2

السعر المستهدف للمحللين

Hold
KWD 401.000 +32.9%
Low: KWD 350.000 High: KWD 480.000
مكرر الربحية المستقبلي
21.0
ربحية السهم المستقبلية
KWD 14.384
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
6.4 B

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 21.585
KWD 21.029 – KWD 21.975
8.3 B 1
FY2029 KWD 20.268
KWD 19.746 – KWD 20.634
8 B 1
FY2028 KWD 17.875
KWD 16.679 – KWD 19.624
7.5 B 3

النقاط الرئيسية

Revenue grew 3.24% annually over 5 years — modest growth
ROE of 29.28% indicates high profitability
Net margin of 20.30% shows strong profitability
Generating 539.81M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 3.75%
Cash machine — converts 84.00% of earnings into free cash flow

النمو

Revenue Growth (5Y)
3.24%
Revenue (1Y)6.99%
Earnings (1Y)0.75%
FCF Growth (3Y)10.49%

الجودة

Return on Equity
29.28%
ROIC16.88%
Net Margin20.30%
Op. Margin28.22%

الأمان

Debt / Equity
0.55
Current RatioN/A
Interest Coverage17.59

التقييم

P/E Ratio
27.95
P/B Ratio7.01
EV/EBITDA21.03
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 6.99% Revenue Growth (3Y) 3.47%
Earnings Growth (1Y) 0.75% Earnings Growth (3Y) 0.03%
Revenue Growth (5Y) 3.24% Earnings Growth (5Y) -1.86%
Profitability
Revenue (TTM) 3.17B Net Income (TTM) 642.63M
ROE 29.28% ROA 12.64%
Gross Margin 57.77% Operating Margin 28.22%
Net Margin 20.30% Free Cash Flow (TTM) 539.81M
ROIC 16.88% FCF Growth (3Y) 10.49%
Safety
Debt / Equity 0.55 Current Ratio N/A
Interest Coverage 17.59 Dividend Yield 0.00%
Valuation
P/E Ratio 27.95 P/B Ratio 7.01
P/S Ratio 5.67 PEG Ratio 75.62
EV/EBITDA 21.03 Dividend Yield 0.00%
Market Cap 17.96B Enterprise Value 18.78B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 3.17B 2.96B 2.96B 2.97B 2.79B
Net Income 642.63M 637.83M 642.23M 707.76M 692.84M
EPS (Diluted) 10.76 10.71 10.84 11.73 11.17
Gross Profit 1.83B 1.76B 1.76B 1.72B 1.63B
Operating Income 893.22M 826.35M 817.68M 873.40M 821.71M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 5.08B 4.55B 4.63B 3.28B 3.09B
Total Liabilities 2.52B 2.73B 3.48B 2.78B 2.73B
Shareholders' Equity 2.56B 1.83B 1.15B 504.49M 367.55M
Total Debt 1.41B 1.70B 2.44B 1.66B 1.60B
Cash & Equivalents 587.83M 324.42M 395.08M 480.53M 501.23M
Current Assets 1.99B 1.67B 1.75B 1.76B 1.63B
Current Liabilities 0.0 789.76M 789.58M 785.74M 680.51M

درجات الاستراتيجيات

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
#973 of 1024
18

النشاط الأخير

دخل Cash Flow Compounder
Mar 24, 2026